Arrevus

To develop novel therapeutics for unmet medical needs in areas with high treatment failure rates, few therapeutic options, and serious outcomes.

Arrevus’ initial focus is in infectious diseases. We are leveraging the power of evolutionary design against antibiotic resistant infections.

Insects have developed unique host defense peptides for combating bacterial pathogens. Our Insect Derived Anti-Infective (IDEA) platform enables new therapy development based on these peptides, expanding our infectious disease pipeline.